Global Smart Syringe Market Size, Share & Trends Analysis Report by Products (Active Safety Syringe, Passive Safety Syringe, and Auto-Disable Syringe), By Application (Drug Delivery, Vaccination, and Blood Sample Collection) By End-User (Hospitals And Clinics, Physicians, Diabetes Patients, Psychiatrists, And Others), Forecast Period 2021-2027
The global smart syringe market is anticipated to grow at a significant CAGR of 10.3% during the forecast period. The key driver of market expansion has been the rise in the prevalence of the COVID-19 virus. Furthermore, an increase in the number of needle stick injuries, a high prevalence of blood-borne transmission of diseases such as hepatitis B, C, and HIV as a result of improper injection practices; growth in the adoption of safety syringes; and evolving opportunities in emerging economies such as the development of advanced healthcare infrastructure facilities and technological advancements are all propelling the market forward.
The global smart syringe market is segmented by product, applications, and end-users. The market segmentation based on the product includes an active safety syringe, passive safety syringe, and auto-disable syringe. Among products, auto-disable syringe holds a significant share in the market. Based on applications, the market is segregated into drug delivery, vaccination, and blood sample collection. Further, segmentation based on end-users includes hospitals and clinics, physicians, diabetes patients, psychiatrists, and others.
The global smart syringe market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. North America is anticipated to hold a dominant position in the global smart syringe market. The factor that is propelling the growth of the market in the region includes rising R&D development expenditure in smart syringe development. The presence of a well-established healthcare industry and expanded funding from government organizations in the region is also the driving factor of the market.
The major companies serving the global smart syringe market Becton, Dickinson And Company, B. Braun Melsungen Ag, Baxter International Inc., Medtronic, Merck & Company Inc.. The companies are focusing on product innovations, expansions, mergers & acquisitions, and finding a new market or innovation in their core competency to expand individual market share. For instance, Sharps Technology, Inc. announced plans to manufacture its patented SHARPS PROVENSATM smart safety syringes in the US in July, 2020. Sharps Provensa safety syringes have been approved for sale in the United States by the Food and Drug Administration (FDA).
Research Methodology
The market study of the global smart syringe market is incorporated by extensive primary and secondary research conducted by the research team at research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
- Financial reports of companies involved in the market.
- Whitepapers, research papers, and news blogs.
- Company websites and their product catalog.
The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
- Global Smart Syringe Market Research and Analysis by Product
- Global Smart Syringe Market Research and Analysis by Application
- Global Smart Syringe Market Research and Analysis by End-user
The Report Covers
- Comprehensive research methodology of the global smart syringe market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global smart syringe market.
- Insights about market determinants that are stimulating the global smart syringe market.
- Detailed and extensive market segments with the regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Alshifa Medical Syringe Manufacturing Company
- Axel Bio Corp.
- B. Braun Melsungen
- Baxter International Inc.
- Becton Dickinson Inc.
- Cardiomed Supplies Inc
- Medtronic Plc
- Merck & Company Inc.
- Parker Hannifin Corp
- Retractable Technologies, Inc.
- Smiths Group Plc
- Star Syringe Ltd.
- Terumo Medical Corporation
- Yangzhou Goldenwell Medical Devices Factory